Angiotensin receptor-neprilysin inhibitor and sodium-dependent glucose cotransporter-2 inhibitor-associated renal injury: a pharmacovigilance study.

Published in: Expert opinion on drug safety (2022)

The combination of ARNI and SGLT-2Is was associated with a significantly increased reporting proportion of AKI. However, due to the limitations of the FAERS database, our results required further studies to assess our findings.

Keyphrases

adverse drug
acute kidney injury
angiotensin ii
emergency department
type diabetes
blood glucose
metabolic syndrome
drug induced
electronic health record
insulin resistance
binding protein